Agomab

Biotechnology Research • Antwerp, Flemish Region, Belgium • 51-100 Employees

Company overview

Headquarters	Antwerp, Flemish Region, Belgium
Phone number	+3233189170
Website	agomab.com
NAICS	541714
SIC	873
Founded	2017
Employees	51-100
Socials

Key Contacts at Agomab

Tim Knotnerus

Ceo

Carmen Fleurinck

Sr Med Director

Agomab Email Formats

Agomab uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@agomab.com), used 50% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@agomab.com	50%
{first name}.{last name}	john.doe@agomab.com	40.9%
{first initial}.{second initial}{last name}	j.odoe@agomab.com	9.1%

About Agomab

Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases.

Agomab revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$73,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$100,800,000